[Comparative analysis of the use of symptomatic slow acting drugs for osteoarthritis containing chondroitin sulfate or affecting its biosynthesis in patients with non-specific low back pain].

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)

The study allows us to recommend the use of a parenteral form of cholesterol (Chondroguard, CJSC «PharmFirma «Sotex», Russia) for the treatment of nonspecific LBP with moderate or severe pain, chronic relapsing or persistent course, in combination with NSAIDs and their subsequent cancellation or administration on demand.

Keyphrases

multiple sclerosis
chronic pain
rheumatoid arthritis
pain management
drug induced
neuropathic pain
early onset
high intensity
knee osteoarthritis
disease activity
spinal cord
spinal cord injury
systemic lupus erythematosus
hyaluronic acid
anti inflammatory drugs
postoperative pain